全文获取类型
收费全文 | 185篇 |
免费 | 14篇 |
出版年
2021年 | 2篇 |
2019年 | 3篇 |
2018年 | 4篇 |
2017年 | 2篇 |
2016年 | 3篇 |
2015年 | 2篇 |
2014年 | 5篇 |
2012年 | 10篇 |
2011年 | 5篇 |
2010年 | 8篇 |
2009年 | 10篇 |
2008年 | 5篇 |
2007年 | 4篇 |
2006年 | 5篇 |
2005年 | 3篇 |
2004年 | 5篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2001年 | 9篇 |
2000年 | 4篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 7篇 |
1987年 | 3篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 5篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 3篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1957年 | 2篇 |
1910年 | 2篇 |
1907年 | 1篇 |
1905年 | 1篇 |
1904年 | 3篇 |
排序方式: 共有199条查询结果,搜索用时 15 毫秒
1.
2.
We investigated the anti-obesity effects of the adrenal androgen, dehydroepiandrosterone (DHEA), on genetically predisposed obese lethal yellow mice (Ay/Aw). Secondly, we tested the hypothesis that DHEA promotes its anti-obesity effects by decreasing the activity of glucose-6-phosphate dehydrogenase (G6PDH). We subjected four genotype-sex combinations of yellow and agouti (control) mice to four dietary treatments and determined weight changes, food consumption, and G6PDH activity. Although G6PDH activities of yellow mice were considerably decreased in the 0.4% DHEA treatment group, they were elevated in the 0.0 and 0.1% DHEA treatment groups. In contrast, G6PDH activities of DHEA-treated control agouti mice remained relatively constant. These studies confirm that DHEA prevents the Ay gene from promoting excess fat deposition via some mechanism(s) other than reduced dietary intake. However, the overall absence of agreement between weight change (gain or loss) and G6PDH activity suggests that the anti-obesity activity of DHEA is not mediated via G6PDH. Since yellow obese (Ay/Aw) mice were found to be more susceptible to DHEA's effects than their agouti (Aw/Aw) littermates, Ay appears to induce an altered metabolism in Ay/Aw mice which is more susceptible to the effects of DHEA than the normal metabolism of Aw/Aw mice. 相似文献
3.
High level of divergence of male-reproductive-tract proteins, between Drosophila melanogaster and its sibling species, D. simulans 总被引:1,自引:0,他引:1
We compared male-reproductive-tract polypeptides of Drosophila melanogaster
and D. simulans by using two-dimensional gel electrophoresis. Approximately
64% of male-reproductive-tract polypeptides were identical between two
randomly chosen isofemale lines from these two species, compared with 83%
identity for third-instar imaginal wing-disc polypeptides. Qualitatively
similar differences were found between reproductive tracts and imaginal
discs when D. sechellia was compared with D. melanogaster and with D.
simulans. When genic polymorphism was taken into account, approximately 10%
of male- reproductive-tract polypeptides were apparently fixed for
different alleles between D. melanogaster and D. simulans; this proportion
is the same as that found for soluble enzymes by one-dimensional gel
electrophoresis. Strikingly, approximately 20% of male-reproductive- tract
polypeptides of either D. melanogaster or D. simulans had no detectable
homologue in the other species. We propose that proteins of the Drosophila
male reproductive tract may have diverged more extensively between species
than have other types of proteins and that much of this divergence may
involve large changes in levels of polypeptide expression.
相似文献
4.
I M Elayan D C Cartmill C B Eckersell J Wilkin W W Winder 《Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)》1991,198(1):569-571
Malonyl-CoA, the inhibitor of carnitine palmitoyl transferase I, has been examined in this study in the muscle and liver of diabetic rats. Male Sprague-Dawley rats were rendered diabetic with streptozotocin (6 mg/100 g body wt). The gastrocnemius/plantaris muscles and liver samples were frozen at liquid nitrogen temperature. Muscle malonyl-CoA was 1.8 +/- 0.2 pmol/mg in control rats and 1.5 +/- 0.2 pmol/mg in the diabetic rats. This difference was not statistically significant. Liver malonyl-CoA of control rats was 8.6 +/- 0.8 pmol/mg, in comparison to 4.3 +/- 0.6 pmol/mg in diabetic rats. In the liver, high concentrations of malonyl-CoA inhibit fatty acid oxidation and ketogenesis. Failure of malonyl-CoA to decline in muscle in the diabetic may be responsible in part for the diversion of fatty acids to the liver, thereby enhancing hepatic fatty acid oxidation and ketogenesis. 相似文献
5.
东方粉蝶幼虫有6条马氏管,每条管可以简易地分为四个部分:直肠导,迴肠纲,黄色段和白色段,所有这四个部分首要细胞的顶面都折叠形成微绒毛(特别是迴肠纲,其顶面进一步折叠形成微道),线粒体几乎延伸到微绒毛顶端。在基部,大量基膜折叠形成细胞内管道,向细胞顶部延伸。在细胞质中,有许多线粒体,糙面内质纲和空泡。每一个细胞的细胞核中有一些散的染色质物质,并且外形呈不规则形。在黄色段首要细胞中,有大量证明是由矿物质沉积形成的电子密集颗粒,及猜疑为微孢子原虫的细胞质囊球。上述每段可能具有的功能会在这报告中讨论。 相似文献
6.
Sera from 680 non-diabetic subjects with suspected autoimmune disease were screened for 13 different antibodies. Of the 582 sera found to contain these antibodies, nine bound insulin in an IgG specific enzyme linked immunosorbent assay (micro ELISA). Four of the sera bound human, porcine, and bovine insulins and five bound exclusively human insulin. "Cold" human, porcine, and bovine insulins each displaced, in a dose dependent manner, the four sera which bound all three insulins, but only human insulin displaced the remaining five, porcine and bovine insulins having little or no effect in concentrations up to 1000 U/1. These observations point to the existence of autoantibodies specifically against human insulin in some subjects with established autoimmunity. 相似文献
7.
Abstract— The distribution of hexokinase (ATP: D-hexose 6-phosphotransferase, EC 2.7.1.1) in rat cerebellum, retina, hippocampus, choroid plexus and ependymal cells of the cerebral ventricles, and dorsal root ganglion has been determined, at the light microscopic level, by both immunofluorescence and a histochemical procedure using nitro blue tetrazolium. With the exception of an artifactual staining of the outer photoreceptor segments of retina when the histochemical procedure was used, both methods gave comparable results, from which the following conclusions are drawn:
- (a) The cytoplasm of neuronal cell bodies clearly contained hexokinase, although the relative levels varied markedly among different types of neurons; such variations have previously been detected by direct assay of hexokinase in dissected neuronal cell bodies (Kato & Lowry , 1973a).
- (b) Glial cells contained readily detectable levels of hexokinase: the immunofluorescence technique revealed spidery glial processes within the myelinated tracts; in other areas, glial cell cytoplasms were indistinguishable from surrounding neuropil, indicating comparable levels of hexokinase; the satellite glia of dorsal root ganglia actually contained higher levels than did adjacent large neurons. The present results, therefore, do not support previous suggestions that glia are characteristically low and neurons characteristically high in hexokinase content.
- (c) Hexokinase was distributed throughout neuropil areas, with a somewhat speckled appearance suggesting the existence of small localizations of relatively higher activity, the nature of which could not be determined at this level of resolution; the hexokinase level in neuropil was clearly higher than that of white fiber tracts, in agreement with previous direct biochemical measurements (Buell et al., 1958)
- (d) No detectable levels of hexokinase were found in cell nuclei.
- (e) Regions expected to be rich in nerve terminals (e.g. the cerebellar glomeruli, the plexiform layers of retina) showed relatively high hexokinase levels compared to the cytoplasm of adjacent neuronal perikarya, in agreement with previous subcellular fractionation experiments which indicated relatively high levels of hexokinase in nerve endings (Wilson , 1972). Considered along with the‘high affinity’glucose transport system in nerve endings (Diamond & Fishman , 1973), these results suggest nerve terminals are well adapted for the'efficient acquisition and introduction of glucose into metabolism.
- (f) In addition, high levels of hexokinase were observed in the inner photoreceptor segments of retina, and in the ependymal and choroid plexus cells of the ventricles.
8.
High concentrations of thyroid-stimulating hormone (TSH) in the serum have often been reported in apparently euthyroid patients with damaged thyroids. We have confirmed this finding in 14 patients 18 months after subtotal thyroidectomy for Graves''s disease (group 1) and in 14 patients with manic-depressive psychosis (group 2) receiving lithium carbonate, which reduces thyroid reserve. One factor common to groups 1 and 2 but not to the controls was reduced thyroid reserve or functioning capacity, and, using established physical principles of servo-control, we have tried to define the mechanism. A series of curves were projected to indicate how TSH might be expected to vary with functioning thyroid capacity. 相似文献
9.
A double blind study was undertaken to determine the effectiveness or oral prostaglandin E2 as a means of improving the pelvic score prior to induction of labour. 48 patients who were greater than 37 were gestation and who had Bishop scores of less than 6 entered the study. Ten tablets were given on an hourly regime. Of 25 patients in the prostaglandin group, 17 were considered successes (68.0%), whereas of 23 patients who received a placebo, 9 were successes (39.1%). No adverse effects were recorded. Prostaglandin E2 is therefore considered a safe and effective method for priming the unfavourable cervix prior to induction of labour. 相似文献
10.
R Curtis H J Stewart S M Hall G P Wilkin R Mirsky K R Jessen 《The Journal of cell biology》1992,116(6):1455-1464
Recently it has been demonstrated that the growth-associated protein GAP-43 is not confined to neurons but is also expressed by certain central nervous system glial cells in tissue culture and in vivo. This study has extended these observations to the major class of glial cells in the peripheral nervous system, Schwann cells. Using immunohistochemical techniques, we show that GAP-43 immunoreactivity is present in Schwann cell precursors and in mature non-myelin-forming Schwann cells both in vitro and in vivo. This immunoreactivity is shown by Western blotting to be a membrane-associated protein that comigrates with purified central nervous system GAP-43. Furthermore, metabolic labeling experiments demonstrate definitively that Schwann cells in culture can synthesize GAP-43. Mature myelin-forming Schwann cells do not express GAP-43 but when Schwann cells are removed from axonal contact in vivo by nerve transection GAP-43 expression is upregulated in nearly all Schwann cells of the distal stump by 4 wk after denervation. In contrast, in cultured Schwann cells GAP-43 is not rapidly upregulated in cells that have been making myelin in vivo. Thus the regulation of GAP-43 appears to be complex and different from that of other proteins associated with nonmyelin-forming Schwann cells such as N-CAM, glial fibrillary acidic protein, A5E3, and nerve growth factor receptor, which are rapidly upregulated in myelin-forming cells after loss of axonal contact. These observations suggest that GAP-43 may play a more general role in the nervous system than previously supposed. 相似文献